trimetazidine has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoedo, ND; Baste, JM; Bégueret, H; Bellance, N; Bellvert, F; Claverol, S; Dard, L; Dugot-Senan, N; Dumon, E; Dupis, A; Esteves, P; Gales, L; Guyonnet-Dupérat, V; Izotte, J; Kieffer, Y; Lacombe, D; Mafhouf, W; Mechta-Grigoriou, F; Obre, E; Palama, T; Pierri, CL; Punzi, G; Redonnet-Vernhet, I; Rezvani, HR; Rodrigues, MF; Rossignol, R; Rousseau, B; Sarlak, S; Thumerel, M | 1 |
| Altuwaijri, S; Andela, VB; Rosier, RN; Wood, J | 1 |
2 other study(ies) available for trimetazidine and Lung Neoplasms
| Article | Year |
|---|---|
Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas.
Topics: Cell Line, Tumor; Drug Delivery Systems; Electron Transport Complex I; Humans; Lung Neoplasms; Mitochondrial Trifunctional Protein, alpha Subunit; Neoplasm Proteins; Oxidation-Reduction; Trimetazidine | 2021 |
Inhibition of beta-oxidative respiration is a therapeutic window associated with the cancer chemo-preventive activity of PPARgamma agonists.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Chromans; Coenzyme A Ligases; Fatty Acid Synthases; Fatty Acids; Gene Expression; Glucose; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Synthase; Lung Neoplasms; Mice; Neoplasms, Experimental; Oxidation-Reduction; Oxygen Consumption; PPAR gamma; Thiazolidinediones; Trimetazidine; Troglitazone | 2005 |